🆚 Clickskeks vs. Iubenda
- 📈 Iubenda is much more popular than Clickskeks.
- 🌎 Iubenda is more popular in Italy, the United States, and the United Kingdom.
- 🌍 Clickskeks is more popular in Austria.
IubendaType
About
Clickskeks is a consent management platform designed specifically for Austrian and German customers.
Iubenda is a privacy compliance platform for websites and apps that generates consent banners, manages regional privacy requirements, and blocks cookies and trackers until users grant consent.
It detects cookies, pixels, and trackers through automated site scans, updates banners automatically as laws change, logs all consent decisions in real time, adapts to GDPR, ePrivacy, and US state laws, integrates with Google Consent Mode v2, and supports the IAB TCF.
Headquarters
Pricing
(100 pages)€5.90/month
(500 pages)€10.90/month
(5,000 pages)€24.90/month
(> 5,000 pages)€44.90/month
(25K pageviews)$6.99/month
(50K pageviews)$27.99/month
(150K pageviews)$119.99/month
Categories
Popularity
Determined by the number of sites using each technology.
Market share
Popularity by country
Determined by the number of sites detected from each country.
Awards
- 🔥 12nd most popular in Austria in the Consent Management category.
- ⬆️ 28th most popular in Germany in the Consent Management category.
- 🥇 Most popular in Italy in the Consent Management category.
- 🥇 Most popular in San Marino in the Consent Management category.
Popularity by domain category
Determined by the number of sites in each category.
Top sites
Top-ranked sites that use these technologies.
Compare alternatives
Technologies with similar characteristics.
Complianz
Cookiebot
Truendo
InMobi CMP🗃️ About This Data
- We evaluate the popularity of technologies based on the number of websites where we detect their usage.
- Technologies without a detectable web footprint, and those we do not track, are not reflected in the calculated market share.
- This report is based on the analysis of 3,406,701 websites.
- Statistics were last calculated on .
- For more details, see our methodology and disclaimer.